News Focus
News Focus
icon url

ghmm

03/22/13 9:25 AM

#158674 RE: DewDiligence #158670

Does HyQvia set a record for most scrabble points by a drug? (I forget which one you pointed out before).

Thanks for the PM I clarified my prior post.
icon url

ghmm

03/22/13 9:26 AM

#158675 RE: DewDiligence #158670

icon url

DewDiligence

03/25/13 8:36 AM

#158772 RE: DewDiligence #158670

EMA declines to give SNY’s Aubagio NAS* status, which means generic versions could hit the European market in a few years:

http://in.reuters.com/article/2013/03/25/us-sanofi-aubagio-idINBRE92O06820130325

*New Active Substance, equivalent to NCE status conferred by the FDA.
icon url

DewDiligence

03/27/13 3:35 PM

#158915 RE: DewDiligence #158670

FDA approves Tecfidera (BG-12) for multiple sclerosis:

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345528.htm
icon url

DewDiligence

08/30/13 11:46 AM

#165842 RE: DewDiligence #158670

EU Commission rubber stamps CHMP approval of SNY's Aubagio for MS:

http://finance.yahoo.com/news/european-commission-approves-genzyme-once-153300297.html

In this case, the formal ratification by the EU Commission took longer than the typical 2-3months following CHMP endorsement.